Journal of Neuro-Oncology

, Volume 105, Issue 3, pp 539–545

Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database

  • Senthil K. Selvanathan
  • Salah Hammouche
  • Heidi J. Salminen
  • Michael D. Jenkinson
Clinical Study – Patient Study

Abstract

Anaplastic ganglioglioma (AGG) are rare central nervous system tumours. Patient and treatment factors associated with outcome are poorly defined and limited to small retrospective case series and single case reports. Using the Surveillance, Epidemiology, and End Results (SEER) cancer registry, we investigated potential clinicopathological factors that can affect outcome in patients with anaplastic ganglioglioma. Patients with anaplastic ganglioglioma diagnosed between 1973 and 2007 were identified from the SEER database. Kaplan–Meier survival analysis and Cox models were used to examine the effect of variables on overall survival. The variables analysed included patient age at diagnosis, gender, race, tumour location, uni-focal or multi-focal tumour, surgical resection and the use of adjuvant radiotherapy. Fifty-eight patients were identified, with a median age at diagnosis of 25.5 years. Ninety-three percent of patients underwent surgery and 36% received adjuvant radiotherapy. The median overall survival was 28.5 months. The most common tumour site was the temporal lobe (27%). Univariate and multivariate analysis identified surgery and uni-focal disease as important predictors of overall survival. Adjuvant radiotherapy did not influence overall survival. This study represents the largest analysis of anaplastic ganglioglioma to date. Furthermore it also emphasises the role of national tumour databases for furthering our understanding of rare brain tumours and determining management options.

Keywords

Anaplasia Ganglioglioma SEER Epidemiology Survival 

References

  1. 1.
    Luyken C, Blümcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J (2004) Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101(1):146–155PubMedCrossRefGoogle Scholar
  2. 2.
    Kalyan-Raman UP, Olivero WC (1987) Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up. Neurosurgery 20(3):428–433PubMedCrossRefGoogle Scholar
  3. 3.
    Suzuki H, Otsuki T, Iwasaki Y, Katakura R, Asano H, Tadokoro M, Suzuki Y, Tezuka F, Takei H (2002) Anaplastic ganglioglioma with sarcomatous component: an immunohistochemical study and molecular analysis of p53 tumor suppressor gene. Neuropathology 22(1):40–47PubMedCrossRefGoogle Scholar
  4. 4.
    Kawataki T, Sato E, Sato T, Kinouchi H (2010) Anaplastic ganglioglioma with malignant features in both neuronal and glial components-case report. Neurol Med Chir (Tokyo) 50(3):228–231CrossRefGoogle Scholar
  5. 5.
    Takei H, Dauser R, Su J, Chintagumpala M, Bhattacharjee MB, Jones J, Adesina AM (2007) Anaplastic ganglioglioma arising from a Lhermitte-Duclos-like lesion. Case report. J Neurosurg 107(2 Suppl):137–142PubMedGoogle Scholar
  6. 6.
    Matsuzaki K, Uno M, Kageji T, Hirose T, Nagahiro S (2005) Anaplastic ganglioglioma of the cerebellopontine angle. Case report. Neurol Med Chir (Tokyo) 45(11):591–595CrossRefGoogle Scholar
  7. 7.
    Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M (2008) Tumor recurrence and malignant progression of gangliogliomas. Cancer 113(12):3355–3363PubMedCrossRefGoogle Scholar
  8. 8.
    Allegranza A, Pileri S, Frank G, Ferracini R (1990) Cerebral ganglioglioma with anaplastic oligodendroglial component. Histopathology 17(5):439–441PubMedCrossRefGoogle Scholar
  9. 9.
    Araki M, Fan J, Haraoka S, Moritake T, Yoshii Y, Watanabe T (1999) Extracranial metastasis of anaplastic ganglioglioma through a ventriculoperitoneal shunt: a case report. Pathol Int 49(3):258–263PubMedCrossRefGoogle Scholar
  10. 10.
    Campos MG, Zentner J, Ostertun B, Wolf HK, Schramm J (1994) Anaplastic ganglioglioma: case report and review of the literature. Neurol Res 16(4):317–320PubMedGoogle Scholar
  11. 11.
    Danjoux M, Sabatier J, Uro-Coste E, Roche H, Delisle MB (2001) Anaplastic temporal ganglioglioma with spinal metastasis. Ann Pathol 21(1):55–58PubMedGoogle Scholar
  12. 12.
    Kang DH, Lee CH, Hwang SH, Park IS, Han JW, Jung JM (2007) Anaplastic ganglioglioma in a middle-aged woman: a case report with a review of the literature. J Korean Med Sci 22(Suppl):S139–S144 ReviewPubMedCrossRefGoogle Scholar
  13. 13.
    Bevilacqua G, Sarnelli R (1979) Ganglioglioma of the spinal cord. A case with a long survival. Acta Neuropathol 48(3):239–242PubMedCrossRefGoogle Scholar
  14. 14.
    Nakajima M, Kidooka M, Nakasu S (1998) Anaplastic ganglioglioma with dissemination to the spinal cord: a case report. Surg Neurol 49(4):445–448PubMedCrossRefGoogle Scholar
  15. 15.
    Tarnaris A, O’Brien C, Redfern RM (2006) Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy. Clin Neurol Neurosurg 108(8):761–767PubMedCrossRefGoogle Scholar
  16. 16.
    Mittelbronn M, Schittenhelm J, Lemke D, Ritz R, Nägele T, Weller M, Meyermann R, Beschorner R (2007) Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components. Neuropathology 27(5):463–467PubMedCrossRefGoogle Scholar
  17. 17.
    Sasaki A, Hirato J, Nakazato Y, Tamura M, Kadowaki H (1996) Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report. J Neurosurg 84(6):1055–1059PubMedCrossRefGoogle Scholar
  18. 18.
    Karabekir HS, Balci C, Tokyol C (2006) Primary spinal anaplastic ganglioglioma. Pediatr Neurosurg 42(6):374–378PubMedCrossRefGoogle Scholar
  19. 19.
    Johannsson JH, Rekate HL, Roessmann U (1981) Gangliogliomas: pathological and clinical correlation. J Neurosurg 54(1):58–63PubMedCrossRefGoogle Scholar
  20. 20.
    Hall WA, Yunis EJ, Albright AL (1986) Anaplastic ganglioglioma in an infant: case report and review of the literature. Neurosurgery 19(6):1016–1020PubMedCrossRefGoogle Scholar
  21. 21.
    Jay V, Squire J, Becker LE, Humphreys R (1994) Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis. Cancer 73(11):2862–2868PubMedCrossRefGoogle Scholar
  22. 22.
    Hirose T, Kannuki S, Nishida K, Matsumoto K, Sano T, Hizawa K (1992) Anaplastic ganglioglioma of the brain stem demonstrating active neurosecretory features of neoplastic neuronal cells. Acta Neuropathol 83(4):365–370PubMedCrossRefGoogle Scholar
  23. 23.
    Nair V, Suri VS, Tatke M, Saran RK, Malhotra V, Singh D (2004) Gangliogliomas: a report of five cases. Indian J Cancer 41(1):41–46PubMedGoogle Scholar
  24. 24.
    Kitano M, Takayama S, Nagao T, Yoshimura O (1987) Malignant ganglioglioma of the spinal cord. Acta Pathol Jpn 37(6):1009–1018PubMedGoogle Scholar
  25. 25.
    Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR, Miller DC (1993) Central nervous system gangliogliomas. Part 2: clinical outcome. J Neurosurg 79(6):867–873PubMedCrossRefGoogle Scholar
  26. 26.
    Di Patre PL, Payer M, Brunea M, Delavelle J, De Tribolet N, Pizzolato G (2004) Malignant transformation of a spinal cord ganglioglioma—case report and review of the literature. Clin Neuropathol 23(6):298–303PubMedGoogle Scholar
  27. 27.
    Mittler MA, Walters BC, Fried AH, Sotomayor EA, Stopa EG (1999) Malignant glial tumor arising from the site of a previous hamartoma/ganglioglioma: coincidence or malignant transformation? Pediatr Neurosurg 30(3):132–134PubMedCrossRefGoogle Scholar
  28. 28.
    Kurian NI, Nair S, Radhakrishnan VV (1998) Anaplastic ganglioglioma: case report and review of the literature. Br J Neurosurg 12(3):277–280PubMedCrossRefGoogle Scholar
  29. 29.
    Demierre B, Stichnoth FA, Hori A, Spoerri O (1986) Intracerebral ganglioglioma. J Neurosurg 65(2):177–182PubMedCrossRefGoogle Scholar
  30. 30.
    Whittle IR, Mitchener A, Atkinson HD, Wharton SB (2002) Anaplastic progression in low grade glioneural neoplasms. Acta Neuropathol 104(2):215PubMedCrossRefGoogle Scholar
  31. 31.
    Demarchi R, Abu-Abed S, Munoz D, Loch Macdonald R (2011) Malignant ganglioglioma: case report and review of literature. J Neurooncol 101(2):311–318PubMedCrossRefGoogle Scholar
  32. 32.
    Im SH, Chung CK, Cho BK, Wang KC, Yu IK, Song IC, Cheon GJ, Lee DS, Kim NR, Chi JG (2002) Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol 59(2):173–183PubMedCrossRefGoogle Scholar
  33. 33.
    Rumana CS, Valadka AB (1998) Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery 42(5):1038–1043 ReviewPubMedCrossRefGoogle Scholar
  34. 34.
    Blümcke I, Wiestler OD (2002) Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 61(7):575–584 ReviewPubMedGoogle Scholar
  35. 35.
    Rumana CS, Valadka AB, Contant CF (1999) Prognostic factors in supratentorial ganglioglioma. Acta Neurochir (Wien) 141(1):63–68CrossRefGoogle Scholar
  36. 36.
    Sutton LN, Packer RJ, Rorke LB, Bruce DA, Schut L (1983) Cerebral gangliogliomas during childhood. Neurosurgery 13(2):124–128PubMedCrossRefGoogle Scholar
  37. 37.
    Wolf HK, Müller MB, Spänle M, Zentner J, Schramm J, Wiestler OD (1994) Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol 88(2):166–173PubMedCrossRefGoogle Scholar
  38. 38.
    Nelson JS, Bruner JM, Wiestler OD, VandenBerg SR (2000) Ganglioglioma and gangliocytoma. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumors of the nervous system. IARC Press, Lyon, pp 96–98Google Scholar
  39. 39.
    Karremann M, Pietsch T, Janssen G, Kramm CM, Wolff JE (2009) Anaplastic ganglioglioma in children. J Neurooncol 92(2):157–163PubMedCrossRefGoogle Scholar
  40. 40.
    Prayson RA (2006) Ganglion cell tumors: gangliocytoma, ganglioglioma and anaplastic ganglioglioma. In: McLendon RE, Rosenblum MK, Bigner DD (eds) Russell and Rubinstein’s pathology of tumors of the nervous system, 7th edn. Hodder Arnold, London, pp 305–320Google Scholar
  41. 41.
    Haddad SF, Moore SA, Menezes AH, VanGilder JC (1992) Ganglioglioma: 13 years of experience. Neurosurgery 31(2):171–178PubMedCrossRefGoogle Scholar
  42. 42.
    Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T, ALA-Glioma study group (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62(3):564–576PubMedCrossRefGoogle Scholar
  43. 43.
    Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981–22981/CE.3. Lancet Oncol 9(1):29–38PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2011

Authors and Affiliations

  • Senthil K. Selvanathan
    • 1
  • Salah Hammouche
    • 2
  • Heidi J. Salminen
    • 3
  • Michael D. Jenkinson
    • 4
  1. 1.Department of NeurosurgerySalford Royal Foundation TrustStott LaneUK
  2. 2.Institute of Medical and Biological EngineeringUniversity of LeedsLeedsUK
  3. 3.Department of Paediatric SurgeryBirmingham Children’s HospitalBirminghamUK
  4. 4.Walton Centre for Neurology and NeurosurgeryLower LaneLiverpoolUK

Personalised recommendations